GlaxoSmithKline PLC | Ownership
Companies that own GlaxoSmithKline PLC
BlackRock Investment Management (UK) Ltd.
128,063,127
2.58%
-9,102,349
0.72%
03/02/2018
The Vanguard Group, Inc.
105,550,271
2.13%
-18,204,729
0.07%
08/01/2018
Norges Bank Investment Management
105,546,000
2.13%
545,000
0.3%
08/01/2018
Legal & General Investment Management Ltd.
103,175,507
2.08%
4,343,726
0.96%
08/01/2018
BlackRock Advisors (UK) Ltd.
88,133,021
1.78%
0
0.73%
03/02/2018
Dodge & Cox
85,103,000
1.72%
0
0.91%
08/01/2018
Schroder Investment Management Ltd.
68,930,401
1.39%
-954,155
0.9%
08/01/2018
Threadneedle Asset Management Ltd.
61,326,955
1.24%
-92,442
1.92%
08/01/2018
Silchester International Investors LLP
58,415,780
1.18%
-1,697,152
5.76%
08/01/2018
Causeway Capital Management LLC
53,747,037
1.08%
-854,897
2.45%
08/01/2018
| Address |
980 Great West Road
Brentford Greater London TW8 9GS
United Kingdom
|
|
Employees
|
- |
| Website |
http://gsk.com |
| Updated |
07/08/2019 |
| GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. |
